Close

Alnylam Pharma (ALNY): Cutting PT On Sanofi Revenue Share But Reiterating Buy - Needham

Go back to Alnylam Pharma (ALNY): Cutting PT On Sanofi Revenue Share But Reiterating Buy - Needham